Literature DB >> 2801485

Arterial plasma norepinephrine correlates to blood pressure in middle-aged men with sustained essential hypertension.

S E Kjeldsen1, N J Schork, P Leren, I K Eide.   

Abstract

Increased plasma catecholamine levels assessed from the venous blood have been found in a number of studies of younger patients with essential hypertension, but hypertensive-normotensive differences could not easily be demonstrated in subjects above 40 years of age. For several reasons, measurement of arterial plasma catecholamines may be a more sensitive tool for the detection of hypertensive-normotensive differences. The present study therefore aimed at examining both venous and arterial plasma catecholamines in a group of white men, all 50 years of age, with never-treated, established essential hypertension (n = 61, blood pressure 165 +/- 2/112 +/- 1 mm Hg, means +/- SE) and comparing them with a similar group of normotensive men (n = 51, blood pressure 128 +/- 1/85 +/- 1 mm Hg). Arterial and venous plasma epinephrine, heart rate, and body weight were significantly elevated in the hypertensive group. Plasma norepinephrine was similar between the groups in the venous blood, whereas in the arterial blood the values in hypertensive subjects were moderately, but significantly increased (p less than 0.03). However, stepwise multiple regression analysis suggested arterial plasma norepinephrine was the only significant independent explanatory variable of raised blood pressure in the hypertensive group (r = 0.51, t = 4.05, p = 0.0002). Such a relationship was not found in the normotensive group. Thus based on measurements in arterial blood, we conclude that plasma norepinephrine, representing sympathetic tone, may be an important pathogenetic factor for high blood pressure in middle-aged men with established hypertension.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2801485     DOI: 10.1016/0002-8703(89)90592-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

Review 1.  Centrally acting antihypertensive drugs: re-emergence of sympathetic inhibition in the treatment of hypertension.

Authors:  C R Benedict
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

Review 2.  The prognostic significance of heart rate for cardiovascular disease and hypertension.

Authors:  Trygve B Tjugen; Arnljot Flaa; Sverre E Kjeldsen
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

Review 3.  A basic science view of acute kidney injury biomarkers.

Authors:  Jennifer R Charlton; Didier Portilla; Mark D Okusa
Journal:  Nephrol Dial Transplant       Date:  2014-01-02       Impact factor: 5.992

Review 4.  Resistant Hypertension and Renal Nerve Denervation.

Authors:  Matthew G Denker; Debbie L Cohen
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Oct-Dec

Review 5.  Renal Denervation Therapy for Drug-Resistant Hypertension: Does It Still Work?

Authors:  Venkatesh K Raman; Costas Tsioufis; Michael Doumas; Vasilios Papademetriou
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-05

Review 6.  Catheter-based Renal Artery Denervation for Resistant Hypertension: Promise Unfulfilled or Unsettled?

Authors:  Matthew G Denker; Debbie L Cohen; Raymond R Townsend
Journal:  Curr Atheroscler Rep       Date:  2015-10       Impact factor: 5.113

7.  Sympathetic nervous system in salt-sensitive and obese hypertension: amelioration of multiple abnormalities by a central sympatholytic agent.

Authors:  P Ernsberger; R J Koletsky; L A Collins; D Bedol
Journal:  Cardiovasc Drugs Ther       Date:  1996-06       Impact factor: 3.727

8.  Calcitonin gene-related peptide (CGRP) in autonomic cardiovascular regulation and vascular structure.

Authors:  Tu H Mai; Jing Wu; André Diedrich; Emily M Garland; David Robertson
Journal:  J Am Soc Hypertens       Date:  2014-03-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.